Skip to main content

David Calkins Archives

Calkins named Assistant VP for Research at VUMC

Dec. 10, 2020—David Calkins, PhD, director of the Vanderbilt Vision Research Center and vice chair and director for Research of the Department of Ophthalmology and Visual Sciences, has been appointed Assistant Vice President for Research at Vanderbilt University Medical Center.

Read more


StrategyShare2020 presents thought-provoking sessions

Oct. 7, 2020—Although the global COVID-19 pandemic forced StrategyShare2020 organizers to rapidly transform the event to an online-only format, there were no compromises in the quality and depth of the presentations, and more than 1,000 individuals registered to participate interactively, a record number for the annual event.

Read more


Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease

Jul. 20, 2020—Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

Read more


StrategyShare 2020 to proceed in virtual sessions

Jul. 15, 2020—New dates and a revised, virtual format have been announced for StrategyShare2020, with the first session on Sept. 29.

Read more


Eye Institute receives $10 million gift for vision research efforts

Jul. 25, 2019—The Vanderbilt Eye Institute (VEI) has received a $10 million gift that will fund regenerative visual neuroscience research to develop transformative therapies for eye diseases.

Read more


Calkins lands innovation award from Research to Prevent Blindness

Jun. 28, 2018—Jun. 28, 2018—David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has been granted one of the preeminent awards in vision research — the Research to Prevent Blindness (RPB) Stein Innovation Award.

Read more


Glaucoma study finds brain fights to preserve vision

Feb. 22, 2018—A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision.

Read more


Vision conference brings together research groups from across the Southeast

Oct. 5, 2017—The Vanderbilt Eye Institute (VEI) recently hosted the Southeastern Vision Conference to celebrate and share excellence in vision science.

Read more


A solar eclipse can hurt your eyesight without you knowing it – here’s why.

Aug. 15, 2017—While agreeing that viewing a total solar eclipse is a chance of a lifetime, Vanderbilt Eye Institute Research Director David Calkins urges us to not look at the sun without special eclipse glasses. Catkins explains how certain spectrums of sunlight can damage your eyesight without you knowing it, until it is too late. Follow Vanderbilt...

Read more


‘Audacious’ grant spurs research on retina regeneration

Sep. 1, 2016—Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina.

Read more


VEI receives grant from Research to Prevent Blindness for research and education

Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.

Read more


Retinal neuron survival in glaucoma

Dec. 16, 2014—Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more